Atovaquone
- 1 July 1995
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 50 (1) , 176-196
- https://doi.org/10.2165/00003495-199550010-00011
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Adverse Events Associated with Trimethoprim-Sulfamethoxazole and Atovaquone during the Treatment of AIDS-Related Pneumocystis carinii PneumoniaThe Journal of Infectious Diseases, 1995
- Experimental Evaluation Of Combined Prophylaxis Against Murine Pneumocystosis And ToxoplasmosisThe Journal of Infectious Diseases, 1994
- Clinical Experience With Atovaquone: A New Drug for Treating Pneumocystis carinii PneumoniaThe Lancet Healthy Longevity, 1994
- Cytotoxic Effects of Inhibitors of de Novo Pyrimidine Biosynthesis upon Plasmodium falciparumBiochemistry, 1994
- Toxoplasma gondii infection in advanced HIV infectionAIDS, 1994
- The Activity of Atovaquone (566C80) in Murine Toxoplasmosis Is Markedly Augmented when Used in Combination with Pyrimethamine or SulfadiazineThe Journal of Infectious Diseases, 1993
- Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDSThe Lancet, 1992
- Toxoplasmic Encephalitis in AIDSClinical Infectious Diseases, 1992
- Safety and Pharmacokinetics of 566C80, a Hydroxynaphthoquinone with Anti-Pneumocystis carinii Activity: A Phase I Study in Human Immunodeficiency Virus (HIV)-Infected MenThe Journal of Infectious Diseases, 1991
- Prevention and Treatment of Pneumocystis Carinii PneumoniaAnnual Review of Medicine, 1991